In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS 

No. 13-808V 

(Not to be Published) 

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * 

JESSICA DEAN and RYAN DEAN, * Special Master Corcoran 

on behalf of their minor child, I.D., * 

* Filed: November 12, 2015 

 * 

 Petitioners, * Attorney’s Fees and Costs; 

 * Reasonable Basis; Interim Fees; 

 v. * Expert Costs. 

 * 

SECRETARY OF HEALTH AND * 

HUMAN SERVICES, * 

 * 

 Respondent. * 

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * 

Andrew D. Downing, Van Cott & Talamante, PLC, Phoenix, AZ, for Petitioners.

Darryl R. Wishard, U.S. Dep’t of Justice, Washington, DC, for Respondent.

DECISION AWARDING IN PART INTERIM ATTORNEY’S FEES AND COSTS1

On October 17, 2013, Jessica and Ryan Dean filed a petition on behalf of their minor child, 

I.D., seeking compensation under the National Vaccine Injury Compensation Program (the 

“Vaccine Program”).2

 Having filed numerous medical records, along with three reports from two 

experts, Petitioners have now requested an interim award of attorney’s fees and costs. Respondent 

objects that an interim fees award is not warranted at this juncture because the Deans have not 

made the requisite special showing. In the alternative, should I determine that an interim fees award 

is appropriate, Respondent argues that (i) the hourly rate requested for Petitioners’ counsel, 

 

1

 Because this decision contains a reasoned explanation for my actions in this case, I will post it on the United States 

Court of Federal Claims website, in accordance with the E-Government Act of 2002, Pub. L. No. 107-347, §205, 116 

Stat. 2899, 2913 (Dec. 17, 2002) (current version at 44 U.S.C. §3501 (2014)). As provided by 42 U.S.C. § 300aa12(d)(4)(B), however, the parties may object to the decision’s inclusion of certain kinds of confidential information. 

Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any 

information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged 

or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly 

unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole decision will be available to the public. 

Id.

2

 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 

100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) [hereinafter “Vaccine Act” or “the 

Act”]. Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). 
2

Andrew Downing, is not reasonable; (ii) the hours billed by Petitioners’ counsel were excessive 

and unreasonable; and (iii) the hourly rate requested for the retained experts in this case are 

unreasonable. As discussed below, I hereby GRANT IN PART Petitioners’ interim fees 

application, awarding interim attorney’s fees and related costs of $38,104.83, while deferring 

action on any expert-related costs. 

Factual History 

On September 24, 2010, I.D. was born at full term via vaginal delivery, with APGAR 

scores of 8/9. Pet’rs’ Ex. 2 at 81; Pet’rs’ Ex. 3 at 6. On December 21, 2010, I.D. received her first 

dose of diphtheria and tetanus toxoids and acellular pertussis vaccine (“DTaP”)

3

 and haemophilus 

influenza type b vaccine (“Hib”)

4

 with no reported adverse reaction. Pet’rs’ Ex. 2 at 8, 10. On 

February 24, 2011, I.D. received her second dose of DTaP and Hib. Id. at 24. On March 17, 2011, 

I.D. presented with a rash, and was diagnosed with eczema. Id. at 23. 

On May 13, 2011, I.D. saw Dr. Davis, a pediatric neurologist, due to “unusual movements.” 

Pet’rs’ Ex. 2 at 66. Her mother reported that when I.D. experienced a mood change, she would lift 

her hands to and from her face and twist her hands in a flailing-like maneuver. Id. Her neurological 

exam and subsequent electroencephalogram were normal, and Dr. Davis diagnosed her with 

benign stereotypies of childhood (similar to a childhood tic disorder). Id. at 67. 

At I.D.’s nine-month and one-year well-child visits, I.D.’s abnormal movements had 

continued, but I.D. had normal growth and development. Pet’rs’ Ex. 2 at 18. Again, I.D. was 

diagnosed with benign stereotypies of childhood. Id. On December 28, 2011, I.D.’s pediatrician

recorded that I.D. was sensitive to sounds and textures and was a picky eater. Id. at 14. She saw a 

speech and occupational therapist throughout 2012 and 2013 for sensory integration and speech 

delay issues. Id. at 64; Pet’rs’ Ex. 4 at 74. 

On January 21, 2013, Mrs. Dean reported that I.D. had experienced a reaction to her 

February 24, 2011, vaccinations that lasted about a year before resolving. Pet’rs’ Ex. 2 at 72. On 

May 17, 2013, I.D.’s pediatrician wrote a permanent medical exemption from future 

immunizations due to adverse reaction. Id. at 10. However, prior to this time, there is no 

documented discussion in the medical records of adverse reactions to I.D.’s February 24, 2011, 

vaccinations. 

 

3

 The DTaP vaccine is a “combination of diphtheria toxoid, tetanus toxoid, and acellular pertussis vaccine; absorbed 

on an aluminum-adsorbing agent.” Dorland’s Illustrated Medical Dictionary 2015 (32d ed. 2012). 

4

 The Hib vaccine protects against Haemophilus influenza type b, a disease caused by bacteria. Hib disease was the 

leading cause of bacterial meningitis, an infection of the lining of the brain and spinal cord. U.S. Department of Health 

and Human Services, Hib Vaccine: What You Need to Know, Vaccine Information Statement (2015), 

http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hib html. 
3

I.D.’s pediatrician ultimately concluded that I.D. suffered an encephalopathy due to her 

February 24, 2011, vaccinations and diagnosed her with a neuro-encephalopathic reaction. Pet’rs’

Ex. 10. Petitioners now bring this action on behalf of I.D. alleging that I.D. developed significant 

neurological deficits following receipt of the Hib and DTaP vaccines at her 5-month wellness 

exam, which took place on February 24, 2011. Pet. at 1.

Procedural History 

 Petitioners filed this action on October 17, 2013, alleging both a Table and a non-Table 

injury. The alleged Table injury claim is that I.D. suffered an encephalopathy as defined by the 

Vaccine Injury Table. By contrast, the alleged non-Table injury claim is that the vaccinations 

resulted in a central nervous system injury. 

Petitioners thereafter began the process of gathering and filing relevant medical records. 

On December 12, 2013, Petitioners filed their Statement of Completion. ECF No. 10. Following 

this filing, Respondent’s Rule 4(c) report deadline was initially set as February 10, 2014. ECF No. 

13. However, Petitioners expressed interest in exploring settlement and, as such, the deadline was 

suspended. The parties were instructed to file a joint status report on or before March 12, 2014, 

regarding the status of settlement negotiations. ECF No. 14. Those discussions extended into early 

April, at which time Respondent filed a status report indicating that the parties were unable to 

settle this case. ECF No. 18. A status conference was held on April 10, 2014, and I set a deadline 

of June 13, 2014, for the filing of Petitioners’ expert report, with a status report by Respondent to 

follow within thirty days. ECF No. 19. 

Between June and October of 2014, the Deans filed a total of three motions to extend their 

deadline to file an expert report. See generally ECF Nos. 22, 26, and 28. Each was granted, and 

then on October 20, 2014, Petitioners filed an expert report and supporting literature from Dr. 

David Axelrod. ECF No. 30. Respondent filed her Rule 4(c) report on February 6, 2015. ECF No. 

36. In it, she disputes that I.D. experienced an encephalopathy post-vaccination. Id. at 6-7. She 

also argued that Petitioners failed to carry their burden to prove a non-Table injury. Id. at 7. 

Specifically, she noted that Dr. Axelrod’s report’s factual summary was “cursory and inaccurate,”

and he failed to cite to the contemporaneous medical records, instead relying on the parents’ 

statements made much later. Id. at 8-9. She argues that Petitioners also fail under Althen prong 

two, because the treater’s opinion attributing injury to vaccination – which is normally accorded 

significant weight in the Vaccine Program – inappropriately relies on the parents’ statements. Id. 

at 10-11. Finally, Respondent argues that Petitioners fail to meet Althen prong three, because the 

contemporaneous medical records do not support a timeframe consistent with the theory proposed 

by Dr. Axelrod. Id. at 11. 
4

Following a status conference, Petitioners were instructed to file a supplemental expert 

report from Dr. Axelrod or an additional export report from a pediatric neurologist responding to 

the identified issues on or before May 29, 2015. On June 1, 2015, they filed an expert report and 

supporting literature from Dr. Harvey Cantor. ECF No. 39. 

On June 22, 2015, Petitioners filed the present interim fees award application (“Mot.”).

ECF No. 41. Petitioners argue that they have acted in good faith and have established a reasonable 

basis for their claim, and thus fees are generally appropriate. Mot. at 9-10. They also assert that 

their case meets all three criteria set forth by the Federal Circuit in Avera v. Sec’y of Health & 

Human Servs., 515 F.3d 1343, 1352 (Fed. Cir. 2008) for an interim fees award, because (i) the 

case is protracted; (ii) the case involves costly expert testimony; and (iii) the case involves undue 

hardship. Mot. at 10-16. Petitioners further maintain that Mr. Downing’s hourly rate is reasonable, 

as are Petitioners’ experts’ fees. Id. at 17-33. 

The Deans request compensation for Mr. Downing at a rate of $350/hour for the 82.9 hours 

he has expended in this case thus far, for a total of $29,015.00. Id. at 18-20. In addition, they ask 

that an associate attorney, Jordon Redman, be awarded fees in the amount of $195/hour for the 

38.8 hours expended in this case thus far, for a total of $7,566.00, and also seek to recover costs 

for work performed by two legal assistants (Robert Cain and Danielle Avery) billing $100/hour, 

for a joint total of $588.50. Id. at 18, 24. Petitioners also ask for reimbursement of funds paid to 

Drs. Axelrod and Cantor for their initial work on the case, including the preparation of filed expert 

reports, in the total sum of $11,800.00, based on hourly rates of $500 for both. Id. at 30. 

Respondent filed an opposition to the interim award application on July 1, 2015 (“Opp.”).

ECF No. 42. She maintains that the express language of section 15(e)(1) of the Vaccine Act does 

not confer authority on special masters to award interim fees. Opp. at 3-4. She then argues that 

even if interim fees awards are permitted, such award is inappropriate in the present case because 

Petitioners have not met the “necessary” Avera criteria. Id. at 7-8. Respondent does not, however, 

presently contest Petitioners’ good faith in filing the claim, or the claim’s reasonable basis, but 

reserves the right to challenge reasonable basis at a later time. Id. at 7, n.3. 

Respondent further argues that, to the extent I grant an interim award, the $350 hourly rate 

requested for Mr. Downing is unreasonably high. Id. at 12. Respondent suggests a 2013 local rate 

of $290.00/hour; then, factoring in Consumer Price Index inflation, a 2014 local rate of 

$295.00/hour and a 2015 local rate of $296.00/hour.5

Id. at 13-17. Regarding the total hours 

claimed by Mr. Downing, Respondent says that “his work should exhibit more efficiency.” Id. at 

 

5

 Respondent has not asserted any objection to the rates requested for the services of Mr. Redman or the paralegals 

who have provided services on this matter. Opp at 12, n. 9. As such, these issues are conceded by Respondent. Because 

I have independently concluded that these rates are acceptable, I will not be addressing them herein, but instead 

applying the relevant rates to my calculation of the interim award to be granted. 
5

17. Finally, Respondent contends that the rates charged by Petitioners’ experts are unreasonable. 

Id. at 18-19. 

Petitioners replied to Respondent’s Opposition on July 7, 2015. ECF No. 43 (“Reply”). In 

it, the Deans reiterate their earlier argument that the decisions of the Federal Circuit permit the 

recovery of interim fees and costs. Reply at 3-8. With respect to challenging Mr. Downing’s hourly 

rate, Petitioners question whether Respondent’s reliance on the 2014 Real Rate Report and the 

2013 Economics of Law Survey supports the lower hourly rate she urges. Id. at 9. Petitioners also 

object to Respondent’s blanket efficiency objections, noting that Respondent fails to point to any 

specific examples in the record of inefficiency. Id. at 15. Finally, Petitioners address Respondent’s 

claim that Petitioners’ experts’ fees are not reasonable, by reiterating that these experts are entitled 

to the prevailing market rate for the work performed, and that the rates they are charging are in 

fact reasonable. Id. at 15-17. 

On August 13, 2015, the Deans filed a Supplemental Brief providing additional evidence 

that Petitioners’ counsel has not raised his billing rates. See ECF No. 44 (“Supp. Br.”). On August 

18, 2015, Respondent filed a response, urging the Court to disregard such evidence. ECF No. 45. 

Later that day, Petitioners filed a reply acknowledging that Respondent has, in fact, not conceded 

the validity of the rate requested in this case, and is not bound to accept those rates in this instance, 

but that Petitioners merely provided the information due to the similarity to a previous case where 

the information was requested. ECF No. 46. Thereafter, on October 2, 2015, Petitioners filed a 

supplemental brief providing additional information to demonstrate the nature of the burden placed 

on Petitioners’ counsel in carrying expert expenses in the Vaccine Program. ECF No. 50 (“Supp. 

Br. on Undue Burden”). This matter is now ripe for resolution. 

ANALYSIS 

I. An Interim Award is Appropriate in this Case.

Controlling decisions of the Federal Circuit6 permit the recovery of interim fees and costs 

in Vaccine Program cases. Cloer v. Sec’y of Health and Human Servs., 675 F.3d 1358, 1362 (Fed. 

Cir. 2012); Avera, 515 F.3d at 1352. Indeed, as noted in McKellar v. Sec’y of Health and Human 

Servs., “interim fees are permitted even before an entitlement decision is made.” 101 Fed. Cl. 297, 

302 (2011). 

In determining that interim fees awards should be available in Vaccine Program cases, the 

Federal Circuit followed the Supreme Court’s construction of other fee-shifting statutes. Avera, 

 

6

 In this decision, I reference or rely upon both the decisions of special masters as well as the judges of the Court of 

Federal Claims, all of which constitute persuasive, but not binding authority. Hanlon v. Sec’y of Health & Human 

Servs., 40 Fed. Cl. 625, 630 (1998). Federal Circuit decisions, however, are binding on special masters. Guillory v. 

Sec’y of Health & Human Servs., 59 Fed. Cl. 121, 124 (2003), aff’d, 104 Fed. App’x 712 (Fed. Cir. 2004).
6

515 F.3d at 1351-52. Avera, however, did not define precisely the circumstances in which an 

interim award might appropriately be issued – leading other special masters to observe that the 

standards for granting an interim fees award “remain somewhat muddled.” Small v. Sec’y of Health 

& Human Servs., No. 02-1616V, 2014 WL 308297, at *1 (Fed. Cl. Spec. Mstr. Jan. 7, 2014) (citing 

Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372, 1375 (Fed. Cir. 2010)). Avera has thus 

been interpreted as allowing special masters broad discretion in determining whether to award 

interim fees. See, e.g., Kirk v. Sec’y of Health & Human Servs., No. 08-241V, 2009 WL 775396, 

at *1 (Fed. Cl. Spec. Mstr. Mar. 13, 2009) (reading Avera to set a “broad, discretionary vehicle for 

ensuring that petitioners are not punished financially while pursuing their vaccine claim”); Bear v. 

Sec’y of Health & Human Servs., No. 11-362V, 2013 WL 691963, at *4 (Fed. Cl. Spec. Mstr. Feb. 

4, 2013) (Avera provides only “examples and general guidance concerning when interim fees and 

costs might be awarded, leaving the special masters broad discretion to consider many factors in 

considering whether an interim award is appropriate in a particular case”) (emphasis in original). 

The awarding of interim fees must also be based on the more general factors that special 

masters consider, in their discretion to award reasonable fees and costs to unsuccessful petitioners 

(given that an interim request, being made in a case that has yet to be adjudicated, is literally made 

in the context of an “unsuccessful” petition). Thus, a special master asked to make an interim 

award must consider if (i) the petition was brought in good faith;7

 and (ii) there was a reasonable 

basis8

 for the claim for which the petition was brought. Section 15(e)(1); Silva v. Sec’y of Health 

& Human Servs., 108 Fed. Cl. 401, 405 (2012); McKellar, 101 Fed. Cl. at 303 (applying good 

faith/reasonable basis test to interim fees request). 

Here, Respondent contests Petitioners’ interim fees application arguing that (i) interim fees 

are not statutorily authorized as per Section 15(e)(1) of the Vaccine Act; and (ii) to the extent 

special masters are in fact so authorized, then they may only act in limited circumstances, such as 

where a petitioner makes a particularized showing of hardship, and that such circumstances are 

absent in this case. Opp. at 2-3. The first of these objections is often repeated by Respondent in 

 

7

 Determining whether a petition was filed in good faith is a subjective inquiry, and can be established as long as a 

petitioner demonstrates an honest belief that she suffered a compensable vaccine injury. See Di Roma v. Sec’y of 

Health & Human Servs., No. 90-3277V, 1993 WL 496981, at *1 (Fed. Cl. Spec. Mstr. Nov. 18, 1993). This element 

is therefore the more easily established of the two. Austin v. Sec’y of Health & Human Servs., No. 10-362V, 2013 WL 

659574, at *7 (Fed. Cl. Spec. Mstr. Jan. 31, 2013) (“[d]ue to its subjective nature, the standard for good faith is very 

low”). Indeed, some cases stand for the proposition that absent an affirmative showing that a petitioner acted in bad 

faith, a petitioner is entitled to a presumption of good faith. See, e.g., Grice v. Sec’y of Health & Human Servs., 36 

Fed. Cl. 114, 121 (1996). 

8

 The reasonable basis requirement involves an objective inquiry with no such favorable presumption as with 

determining good faith. See McKellar, 101 Fed. Cl. at 303-34 (citing Perreira v. Sec’y of Health & Human Servs., 33 

F.3d 1375 (Fed. Cir. 1994)) (“[t]he petitioner must affirmatively establish a reasonable basis to recover attorneys’ fees 

and costs”). An assessment of reasonable basis “look[s] not at the likelihood of success but more to the feasibility of 

the claim.” Di Roma, 1993 WL 496981, at *1. 
7

opposing interim fees and costs requests,9 but has been repeatedly dispensed with. See, e.g., 

Crutchfield v. Sec’y of Health & Human Servs., No. 09-39V, 2011 WL 3806351, at *2 (Fed. Cl. 

Spec. Mstr. Aug. 4, 2011). In short, I am empowered to grant an interim fees and costs award if I 

deem (in the reasonable exercise of my discretion) that it is appropriate to do so. 

There is more meat on the bones of Respondent’s second argument – that the Deans have 

failed to make a “special showing of hardship” justifying an interim award. Opp. at 5-6, 8 (citing 

McKellar, 101 Fed. Cl. at 300-01). Petitioners respond by attempting to demonstrate that they have 

satisfied each of the Avera criteria. Mot. at 12 (citing Avera, 515 F.3d at 1352). To resolve this 

aspect of Respondent’s objections requires some evaluation of where the case presently stands.

First, I do not find that the matter is notably protracted. In most cases the “protracted 

proceedings” element is only satisfied where several years have passed in a case’s life, or where 

its trajectory is anticipated to take several more years prior to resolution. See, e.g., Roberts v. Sec’y 

of Health & Human Servs., No. 09-427V, 2013 WL 2284989, at *4 (Fed. Cl. Spec. Mstr. Apr. 30, 

2013) (granting interim fees when proceedings had been ongoing for over five years); Jakes v. 

Sec’y of Health & Human Servs., No. 06-831V, 2013 WL 1150518, at *4 (Fed. Cl. Spec. Mstr. 

Feb. 19, 2013) (awarding Mr. Downing interim fees because the case had been ongoing for over 

six years). 

Second, in an effort to demonstrate costliness of expert testimony, the Deans assert that 

their counsel has had to reimburse expert costs of $11,800. Mot. at 33. Although there is no clear 

authority for what standard applies in measuring costliness (see, e.g., Avila v. Sec’y of Health & 

Human Servs., 90 Fed. Cl. 590, 598 (Dec. 22, 2009) (citing Avera, 515 F.3d at 1352)); but see 

Fester v. Sec’y of Health and Human Servs., No. 10-243V, 2013 WL 5367670, at *15 (Fed. Cl. 

Spec. Mstr. Aug. 27, 2013) (determining that “[i]t makes considerable practical sense” to evaluate 

whether expert costs are high based on objective criteria)), I do not find that the particular expert 

costs at issue are notably high from an objective standpoint. $11,800 is not an insignificant amount, 

but it is not a shocking price for the services of two experts. 

Finally, Petitioners and Respondent disagree whether the undue hardship criterion solely 

includes hardship to the Petitioners (Respondent’s position), or whether it should consider hardship 

to both Petitioners and Petitioners’ counsel (Petitioners’ position). Mot. at 14-17; Opp. at 8. I have 

previously decided, however, in cases very similar to the present, that counsel’s burdens in 

litigating a case (and even in litigating multiple Vaccine Program cases) are relevant to evaluating 

hardship, since to do so is consistent with one of the underlying purposes of permitting interim 

fees in the first place. Al-Uffi v. Sec’y of Health & Human Servs., No. 13-956V, 2015 WL 6181669, 

 

9 See, e.g., Thomas v. Sec’y of Health & Human Servs., No. 12-309, 2013 WL 5718948, at *1 (Fed. Cl. Spec. Mstr. 

Sept. 26, 2013); Whitener v. Sec’y of Health & Human Servs., No. 06-477, 2011 WL 1467919, at *1 (Fed. Cl. Spec. 

Mstr. Mar. 25, 2011). 
8

at *8 (Fed. Cl. Spec. Mstr. Sept. 30, 2015). Because an interim fees award will assist the 

representation of the Petitioners in this matter, I deem one appropriate. 

There are no other bases for denial of an interim fees award in this case. Respondent does 

not meaningfully contest Petitioners’ good faith or reasonable basis in bringing this petition. Opp. 

at 7, n. 3.10 And I am not persuaded by Respondent’s argument that interim fees applications should 

only be granted in rare, exceptional instances. As previously discussed, Avera provides special 

masters with “broad discretion” in determining whether to make an interim award. See, e.g., Kirk,

2009 WL 775396, at *1. In the exercise of that discretion, I find an interim fees award11 is 

appropriate in this particular case. 

II. Challenges to the Amounts Requested for Petitioners’ Attorneys.

I must now determine the magnitude of Petitioners’ interim attorney’s fees award. Whether 

a fees award is made on an interim basis or after a case’s conclusion, the requested sum must be 

“reasonable.” Section 15(e)(1). It is for the special master to evaluate and decide whether this is 

the case. See Perreira v. Sec’y of Health & Human Servs., 27 Fed. Cl. 29, 34 (1992), aff’d, 33 F.3d 

1375 (Fed. Cir. 1994). To this end, special masters may in their discretion reduce attorney hours 

sua sponte, apart from objections raised by Respondent and without providing a petitioner notice 

and opportunity to respond. See Sabella v. Sec’y of Health & Human Servs., 86 Fed. Cl. 201, 208-

09 (2009); Perreira, 27 Fed. Cl. at 34 (special master has “wide discretion in determining the 

reasonableness” of attorney’s fees and costs). 

Determining the appropriate amount of an award of reasonable attorney’s fees is a two-part 

process. The first part involves application of the lodestar method – “multiplying the number of 

hours reasonably expended on the litigation times a reasonable hourly rate.” Avera, 515 F.3d at 

1347-48 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). The second part involves adjusting 

the lodestar calculation up or down to take relevant factors into consideration. Id. at 1348. This 

standard for calculating a fee award is considered applicable in most cases where a fees award is 

authorized by federal statute. Hensley v. Eckerhart, 461 U.S. 424, 429-37 (1983). 

A. Proper Hourly Rate 

 

10 Respondent at best indirectly attacks reasonable basis, stating that the two filed expert reports are “weak.” Opp. at 

7, n. 3. But for purposes of the present application, Respondent concedes that sufficient reasonable basis is established 

to make an interim award appropriate. Id. I separately conclude herein that there is sufficient support for Petitioners’

claim to find reasonable basis for the claim’s filing – based on the evidence of Petitioners’ vaccination, onset, and 

injury supported by the medical record, including I.D.’s pediatric treaters. Special Masters have historically accorded 

deference to treaters’ opinions. See, e.g., Andreu v. Sec’y of Health & Human Servs., No. 98-817V, 2008 WL 2517179, 

at *8 (Fed. Cl. Spec. Mstr. May 29, 2008). 

11 I do not, however (for the reasons stated below), find that the present interim award should also include expert costs 

incurred to date. 
9

An attorney’s reasonable hourly rate is more precisely understood to be the “prevailing 

market rate” in the relevant forum. Avera, 515 F.3d at 1349; Rodriguez v. Sec’y of Health & Human 

Servs., No. 06-559V, 2009 WL 2568468, at *2 (Fed. Cl. Spec. Mstr. July 27, 2009), mot. for rev. 

den’d, 91 Fed. Cl. 453 (2010), aff’d, 632 F.3d 1381 (Fed. Cir. 2011). That rate is in turn determined 

by the “forum rule,” which bases the award rate on rates paid to similarly qualified attorneys in 

the forum where the relevant court sits (Washington, DC for Vaccine Program cases). Avera, 515 

F.3d at 1348. After the hourly rate is determined, the reasonableness of the total hours expended 

must be considered. Sabella, 86 Fed. Cl. at 205-06. This reasonableness inquiry involves 

consideration of the work performed on the matter, the skill and experience of the attorneys 

involved, and whether any waste or duplication of effort is evident. Hensley, 461 U.S. at 434, 

437.12

Respondent maintains that Mr. Downing’s requested rate of $350/hour is unreasonable. 13

Id. I recently determined in Al-Uffi, however, that a reasonable hourly rate for Mr. Downing is 

$350/hour. That analysis is broadly consistent with two other recent decisions involving different 

Vaccine Program counsel – Scharfenberger v. Sec’y of Health & Human Servs., No. 11-221V, 

2015 WL 3526559 (Fed. Cl. Spec. Mstr. May 15, 2015), and Special Master Gowen’s decision in 

McCulloch v. Sec’y of Health & Human Servs., No. 09-293, 2015 WL 5634323 (Fed. Cl. Spec. 

Mstr. Sept. 1, 2015), reconsid. den’d, 2015 WL 6181910 (Fed. Cl Spec. Mstr. Sept. 21, 2015). 

I thus find that $350/hour is a reasonable hourly rate for Mr. Downing for work performed 

in 2015. That rate, however, cannot be applied retroactively to work done in previous years, as 

doing so would effectively be the equivalent of charging the government interest. Hocraffer v. 

Sec’y of Health & Human Servs., No. 99-533V, 2011 WL 3705153, at *17-19 (Fed. Cl. Spec. Mstr. 

July 25, 2011). As a result, employing the Consumer Price Index Calculator, Mr. Downing’s rate 

of $350/hour is hereby adjusted to $348/hour for work performed in 2014 and $342/hour for work 

performed in 2013. 

B. Reasonable Hours Worked 

I must also determine if the fees applicant has established the reasonableness of the work 

performed. Mares v. Credit Bureau of Raton, 801 F.2d 1197, 1210 (10th Cir. 1986) (“[i]t remains 

 

12 In some cases, determining the proper hourly rate for a particular attorney requires consideration of whether there 

is a significant disparity between the forum rate applicable to the Vaccine Program generally and the geographic forum 

in which the attorney practices, in order to adjust the rate used for the lodestar calculation. Avera, 515 F.3d at 1349,

(citing Davis Cty. Solid Waste Mgmt. & Energy Recovery Special Serv. Dist. v. EPA, 169 F.3d 755, 758 (D.C. Cir. 

1999)). Here, however, the parties do not dispute that the forum rate and the rate prevailing among Arizona attorneys 

(the geographic locale from which Mr. Downing practices) is substantially equivalent, obviating the need for such rate 

comparison. See Opp. at 13. 

13 As noted above, Respondent does not contest the reasonability of Mr. Redman’s requested rate of $195/hour. I do 

not separately find that particular rate is unreasonable for an attorney with his level of experience, based on the rate 

ranges discussed herein. 
10

counsel’s burden to prove and establish the reasonableness of each dollar, each hour, above 

zero.”).14 In doing so I am not obligated to evaluate an attorney’s billing records on a line-by-line 

basis. Saxton v. Sec’y of Health & Human Servs., 3 F.3d 1517, 1521-22 (Fed. Cir. 1993) (approving 

the special master's elimination of 50 percent of the hours claimed); see also Broekelschen v. Sec’y 

of Health & Huamn Servs., 102 Fed. Cl. 719 at 728-29 (2011) (affirming the special master's 

reduction of attorney and paralegal hours). At bottom, as the Supreme Court instructs, when 

awarding attorney’s fees, special masters may use estimates to achieve “rough justice.” Fox v. 

Vice, 131 S. Ct. 2205, 2216 (2011). 

 Respondent offers a single blanket objection that the hours billed by Mr. Downing are 

“excessive and unreasonable.” Opp. at 17-18. However, this objection is not supported by a single 

example from the record. Id. Because I have not been presented with a basis for adjusting the time 

billed in this matter, and because I see no basis from my review of the record to do so 

independently, Petitioners shall be awarded all the time proposed in their application. This results 

in an attorney’s fees award of $28,805.00 in total ($6,532.20 for 19.1 hours in 2013; $9,952.80 for 

28.6 hours in 2014; and $12,320.00 for 35.2 hours in 2015). 

III. Challenges to Requested Expert Costs. 

The Deans also request an award of interim costs for reimbursement (in the total amount 

of $12,975.33, $11,800 of which was paid to experts) in this case. They have the same burden of 

demonstrating the reasonableness of such costs as they do with respect to attorney’s fees. Perreira, 

27 Fed. Cl. at 34; Presault v. United States, 52 Fed. Cl. 667, 670 (2002); Fester, 2013 WL 

5367670, at *16. 

Here, I am hesitant to award the expert costs for two related reasons. First, the timing of 

the request is slightly premature. Such awards are more commonly granted following the expert’s 

testimony at an entitlement hearing. See, e.g., Robert, 2013 WL 2284989 (granting interim award 

of expert costs after conclusion of hearing but before issuance of entitlement decision); Dobrydnev 

v. Sec’y of Health and Human Servs., 94 Fed. Cl. 134, 148 (2010) (error for special master to deny 

interim fees request to cover incurred expert costs; expert had testified at hearing and needed to be 

compensated for prior work before he would be willing to testify at subsequent rebuttal 

proceeding); see also Crutchfield, 2011 WL 3806351, at *8 (granting interim award of expert costs 

after expert’s testimony at an evidentiary hearing; although petitioner had paid cost of expert’s 

report preparation, it was an undue hardship to require petitioner also cover costs incurred after 

expert testified at trial). No hearing is immediately pending, and there has been no representation 

by the Petitioners that the experts’ appearances are dependent on satisfying their costs in advance.

 

14 Although Mares did not interpret the Vaccine Act’s fees provisions, fee-shifting statutes are interpreted similarly. 

Avera, 515 F.3d at 1348. 
11

Second, I do not find that the expert costs are particularly high. One of the Avera criteria 

for an award of interim costs is whether the matter requires the services of “costly experts,” which 

is best resolved by looking at the issue objectively. Avera, 515 F.3d at 1352; Fester, 2013 WL 

5367670, at *15 (“[a] petitioner or petitioner’s counsel who has expended $100,000 in expert costs 

in a case that may be on review or appeal for several more years certainly presents a more 

compelling case for an interim award than one who has only a $1,000 expert retainer cost 

outstanding”). The amount in question (approaching $12,000) is not insignificant, and I do not 

deny that its satisfaction may impose some burdens on counsel, but they are foreseeable burdens 

in any active litigation that do not independently justify an interim award. 

My reaction to the interim request for expert costs also is influenced by the case’s nature. 

Because I am granting an interim fees award, it follows that (at least at present) I do find the case 

has some reasonable basis. Yet I note that there are evident problems with the claims herein 

(beyond the notable weaknesses in the Table claim). All of the expert reports offered in support of 

both claims seem primarily to rely on statements by Mrs. Dean about I.D.’s vaccination reaction 

rather than the medical records themselves. But it is well accepted in the Vaccine Program that 

ordinarily medical records (and what they reflect about a vacinee’s health) are considered more 

probative than the recollections of interested witnesses. See, e.g., Reusser v. Sec’y of Health & 

Human Servs., 28 Fed. Cl. 516, 523-24 (1993) (“written documentation recorded by a disinterested 

person at or soon after the event at issue is generally more reliable than the recollection of a party 

to a lawsuit many years later”); Robi v. Sec’y of Health & Human Servs., No. 12-352V, 2014 WL 

1677116, at *2-3 (Fed. Cl. Spec. Mstr. Apr. 4, 2014) (citing Cucuras v. Sec’y of Health & Human 

Servs., 993 F.2d 1525, 1528 (Fed. Cir. 1993)) (“[i]n weighing divergent pieces of evidence, special 

masters usually find contemporaneously written medical records to be more significant than oral 

testimony”). Such a case will be difficult to prove, and may turn not on expert testimony at all, 

thus diminishing the value of their participation. It is wiser for me to defer ruling on their costs 

until after I hear their testimony, and can then evaluate the reasonableness of the requested fees in 

light of contribution made to the case by the respective experts. 

Petitioners make several policy arguments as to why an interim award of expert costs is 

justified, but I find them unpersuasive under the circumstances. Petitioners assert that the ability 

of other petitioners to retain competent counsel in the Vaccine Program will be jeopardized if 

attorneys must bear expert costs in many Vaccine Program proceedings without an immediate 

expectation of reimbursement. Supp. Br. on Undue Burden at 3. They argue that because the 

Vaccine Program benefits from having the “highest qualified experts available” to “opine on the 

complicated subject matter involved in these cases,” I should err on the side of awarding such costs 

when requested. Mot. at 30. 

Those sorts of concerns, however, while rational, do not compel an expert costs award 

herein. Vaccine Program experts are likely aware of the favorable fee-shifting provisions of the 
12

Vaccine Act15– and thus that they will be compensated, sooner or later, for reasonable time spent 

on a case (assuming of course the case has reasonable basis). While counsel may initially bear 

some of these costs in prosecuting a petitioner’s claim, that fact alone (given the otherwise 

assurance of eventual payment) is not a basis for an interim fees award – otherwise, “interim fees 

would be the norm.” McKellar, 101 Fed. Cl. at 301. To ask the special master to act otherwise 

requires this Court to partner with counsel in ensuring the successful functioning of their business 

model – something that goes well beyond simply encouraging the availability of representation to 

successful petitioners, while also inviting inappropriate scrutiny into an attorney’s financial 

management of his own practice. Fester, 2013 WL 5367670, at *15 (“[t]o look at such cases 

subjectively would require delving into a law firm’s or expert’s financial situation, a requirement 

that would likely be repellant to the court and law firm alike”).

Petitioners should certainly renew the present expert costs requests later, after their experts 

have carried out their purpose by testifying. At that time, Petitioners may supplement the request 

with statements or invoices recording additional expert costs.16 I defer resolution of this aspect of 

Petitioners’ motion until that time. 

CONCLUSION

 Based on all of the above, the following chart sets forth the total calculation of Petitioners’

interim fees and costs award: 

Contested Sum Amount Requested Reduction Total Awarded

Mr. Downing’s Fees $29,015.00 $210.00 $28,805.00

Associates and Legal 

Assistants Fees

$8,124.50 none $8,124.50

Expert Costs $11,800.00 N/A N/A

Other Costs $1,175.33 None $1,175.3317

 Accordingly, in the exercise of the discretion afforded to me in determining the propriety 

of interim fees awards, and based on the foregoing, I GRANT IN PART Petitioners’ Motion for 

Interim Attorney’s Fees, awarding $38,104.83 in interim fees and costs. I DEFER consideration 

 

15 Indeed, certain experts routinely testify in Vaccine Program cases. It appears Dr. Axelrod himself has participated 

to date in nearly a dozen Vaccine Program cases. 

16 Should this case become more protracted, or the facts change in such a way that the case for an interim award of 

expert costs is more compelling, Petitioners could also renew this portion of her request sooner. And I urge the parties 

to consider stipulating to the award of such fees and costs upon conclusion of the hearing. 

17 Respondent has not objected to these costs. See generally Opp. Because I find them reasonable, I hereby include 

them in the award without adjustment. 
13

of expert costs until a later time. In the absence of a motion for review filed pursuant to RCFC 

Appendix B, the clerk of the court SHALL ENTER JUDGMENT in accordance with the terms 

of this decision.18

IT IS SO ORDERED. 

 

 /s/ Brian H. Corcoran 

Brian H. Corcoran

 Special Master 

 

18 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment if (jointly or separately) they file notices 

renouncing their right to seek review.